PMID- 29291420 OWN - NLM STAT- MEDLINE DCOM- 20180213 LR - 20180213 IS - 1879-0631 (Electronic) IS - 0024-3205 (Linking) VI - 194 DP - 2018 Feb 1 TI - Vitamin C and E chronic supplementation differentially affect hepatic insulin signaling in rats. PG - 196-204 LID - S0024-3205(17)30689-6 [pii] LID - 10.1016/j.lfs.2017.12.039 [doi] AB - AIM: Vitamin C and vitamin E supplementations and their beneficial effects on type 2 diabetes mellitus (T2DM) have been subjected to countless controversial data. Hence, our aim is to investigate the hepatic molecular mechanisms of any diabetic predisposing risk of the chronic administration of different doses of vitamin E or vitamin C in rats. MAIN METHODS: The rats were supplemented with different doses of vitamin C or vitamin E for eight months. KEY FINDINGS: Vitamin C and vitamin E increased fasting blood glucose, insulin, and homeostasis model assessment index for insulin resistance (HOMA). Vitamin C disrupted glucose tolerance by attenuating upstream hepatic insulin action through impairing the phosphorylation and activation of insulin receptor and its subsequent substrates; however, vitamin E showed its effect downstream insulin receptor in the insulin signaling pathway, reducing hepatic glucose transporter-2 (GLUT2) and phosphorylated protein kinase (p-Akt). Moreover, both vitamins showed their antioxidant capabilities [nuclear factor-erythroid-2-related factor 2 (Nrf2), total and reduced glutathione] and their negative effect on Wnt pathway [phosphorylated glycogen synthase kinase-3beta (p-GSK-3beta)], by altering the previously mentioned parameters, inevitably leading to severe reduction of reactive oxygen species (ROS) below the physiological levels. SIGNIFICANCE: In conclusion, a detrimental effect of chronic antioxidant vitamins supplementation was detected; leading to insulin resistance and impaired glucose tolerance obviously through different mechanisms. Overall, these findings indicate that the conventional view that vitamins promote health benefits and delay chronic illnesses and aging should be modified or applied with caution. CI - Copyright (c) 2017. Published by Elsevier Inc. FAU - Ali, Mennatallah A AU - Ali MA AD - Department of Pharmacology &Therapeutics, Faculty of Pharmacy and Drug Manufacturing, Pharos University, Alexandria, Egypt. Electronic address: mennaallah.ismail@pua.edu.eg. FAU - Eid, Rania M H M AU - Eid RMHM AD - Department of Physiology, Faculty of Medicine, Aswan University, Egypt. FAU - Hanafi, Mervat Y AU - Hanafi MY AD - Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt. LA - eng PT - Journal Article DEP - 20171230 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Antioxidants) RN - 0 (Insulin) RN - 0 (Vitamins) RN - 1406-18-4 (Vitamin E) RN - IY9XDZ35W2 (Glucose) RN - PQ6CK8PD0R (Ascorbic Acid) SB - IM MH - Animals MH - Antioxidants/administration & dosage/*pharmacology MH - Ascorbic Acid/administration & dosage/*pharmacology MH - Glucose/metabolism MH - Insulin/*metabolism MH - Insulin Resistance MH - Liver/*drug effects/metabolism MH - Male MH - Oxidative Stress/drug effects MH - Rats MH - Rats, Wistar MH - Signal Transduction/*drug effects MH - Vitamin E/administration & dosage/*pharmacology MH - Vitamins/administration & dosage/*pharmacology MH - Wnt Signaling Pathway/drug effects OTO - NOTNLM OT - GLUT2 OT - Glutathione OT - Insulin resistance OT - Nrf2 OT - Phosphorylated insulin receptor OT - UCP2 OT - Wnt pathway OT - p-Akt EDAT- 2018/01/02 06:00 MHDA- 2018/02/14 06:00 CRDT- 2018/01/02 06:00 PHST- 2017/08/31 00:00 [received] PHST- 2017/12/19 00:00 [revised] PHST- 2017/12/29 00:00 [accepted] PHST- 2018/01/02 06:00 [pubmed] PHST- 2018/02/14 06:00 [medline] PHST- 2018/01/02 06:00 [entrez] AID - S0024-3205(17)30689-6 [pii] AID - 10.1016/j.lfs.2017.12.039 [doi] PST - ppublish SO - Life Sci. 2018 Feb 1;194:196-204. doi: 10.1016/j.lfs.2017.12.039. Epub 2017 Dec 30.